Drugs / Silkworm pupa tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07554807 | Apr 2026 → Dec 2027 expected | digestive system cancer, muscular atrophy, nutritional deficiency disease | First Affiliated Hospital of Zhejiang University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Silkworm pupa tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07554807 ↗ |
| Route | Oral | “2 tablets each time, 3 times daily, taken half an hour before meals” NCT07554807 ↗ |